As a further confirmation of the in vitro findings, SNHG4 silencing in subcutaneously transplanted tumors inhibited tumor growth by decreasing cell cycle regulators, whereas miR-590-3p inhibition exerted the opposite effects. The gene discussed is SNHG4; the disease is neoplasm.